The Library
COVID-19 and diabetes Mellitus : implications for prognosis and clinical management
Tools
Barber, Thomas M. (2020) COVID-19 and diabetes Mellitus : implications for prognosis and clinical management. Expert Review of Endocrinology and Metabolism, 15 (4). 227-236 . doi:10.1080/17446651.2020.1774360 ISSN 1744-6651.
|
PDF
WRAP-COVID-19-diabetes-Mellitus-implications-prognosis-clinical-management-Barber-2020.pdf - Accepted Version - Requires a PDF viewer. Download (949Kb) | Preview |
Official URL: https://doi.org/10.1080/17446651.2020.1774360
Abstract
Introduction: COVID-19 is a novel coronavirus that emerged from Wuhan, China in December 2019, and within 3-months became a global pandemic.
Areas Covered: Pubmed search of published data on COVID-19, respiratory infections and Diabetes Mellitus (DM). DM associates with impairments of both cellular and humoral immunity. Early emergent global data reveal that severity of clinical outcome from COVID-19 infection (including hospitalization and admission to Intensive Care Unit [ICU]), associate with co-morbidities, prominently DM. The key principles of management of COVID-19 in patients with DM include ongoing focused outpatient management (remotely where necessary) and maintenance of good glycaemic control.
Expert Opinion: We will remember the dawn of the third decade of the 21st Century as a time when the world changed, the true scale and impact of which is hard for us to imagine. Like a phoenix from the ashes though, COVID-19 provides us with a great learning opportunity to renew insights into ourselves as individuals, our clinical teams and the optimized provision of care for our patients. COVID-19 has re-shaped and re-focused our collective societal values, with a sea-changed shift from materialistic to human-centric, from self-centredness to altruism, ultimately for the betterment of patient care and the whole of society.
Item Type: | Journal Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Subjects: | R Medicine > RA Public aspects of medicine | ||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||||
Library of Congress Subject Headings (LCSH): | COVID-19 (Disease) , Diabetes -- Epidemiology, Respiratory infections -- Diagnosis | ||||||||
Journal or Publication Title: | Expert Review of Endocrinology and Metabolism | ||||||||
Publisher: | Taylor & Francis | ||||||||
ISSN: | 1744-6651 | ||||||||
Official Date: | 2020 | ||||||||
Dates: |
|
||||||||
Volume: | 15 | ||||||||
Number: | 4 | ||||||||
Page Range: | 227-236 | ||||||||
DOI: | 10.1080/17446651.2020.1774360 | ||||||||
Status: | Peer Reviewed | ||||||||
Publication Status: | Published | ||||||||
Reuse Statement (publisher, data, author rights): | This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Review of Endocrinology and Metabolism on 23 May 2020, available online: http://www.tandfonline.com/10.1080/17446651.2020.1774360 | ||||||||
Access rights to Published version: | Restricted or Subscription Access | ||||||||
Date of first compliant deposit: | 29 May 2020 | ||||||||
Date of first compliant Open Access: | 23 May 2021 |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year